You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萬泰生物(603392.SH):擬購買羅格朗土地及廠房 用於疫苗產業基地建設項目
格隆匯 01-13 21:23

格隆匯 1 月 13日丨萬泰生物(603392.SH)公佈,根據經營發展規劃,為實施疫苗產業基地建設項,萬泰生物羅格朗(北京)電氣有限公司(羅格朗)簽署房地產買賣合同,以人民幣5400萬元價格受讓羅格朗所有的位於北京市昌平區科技園區超前路4號廠區的工業用土地使用及其地上廠房與附屬配套設施

公司廈門大學香港大學合作研發的鼻噴新冠疫苗,已完成臨牀前研究工作,目前已經進入II期臨牀試驗階段具體詳見公司於20201231日披露的《關於藥品臨牀試驗進展的公吿》(公吿編號:2020-066)。由於目前公司地空間不足,不能滿足大規模疫苗生產需要。基於以上原因公司急需購置土地並進行生產線建設,儘快實現公司研發的鼻噴新冠疫苗項目落地。

初步測算,項目總投資46863.68萬元,其中包含土地及廠房購置5400新增專用設備預計8995.56萬元,公用工程設備費用1610萬元以及廠房改造費用等。公司將根據項目的實際進度、資金需求輕重緩急等情況,通過自有資金或銀行貸款相結合的方式支付項目所需款項。

公司擬羅格朗現有廠房基礎上進行適當改擴建用於疫苗產業基地建設項目主要包含GMP標準生產車間及配套設施的建設。另外,需要購置專用生產設備及公用設備建設一條新冠疫苗生產線。

公司將積極與相關主管部門溝通項目涉及的立項、環評以及規劃設計、施工等前期手續辦理等前期手續辦理情況,力爭3個月時間完成報批手續,7個月時間進行廠房改造及生產線建設,力爭1完成全部項目建設。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account